KLRK1 and Miyoshi myopathy: In this study, it was demonstrated that the two MM cell lines used had a high expression of NKG2D ligands (as well as positive staining for MICA, MICB, and ULBP-3), and appeared to correlate with the MM exosomes’ aptitude for more effectively suppressing NKG2D expression on target cells.